(R)-(+)-3-羟基-3-苯丙酸 | 2768-42-5

• 物质功能分类: 医药中间体 - 原料药中间体
• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 中文名称: (R)-(+)-3-羟基-3-苯丙酸
• 中文别名: (R)-3-羟基-3-苯丙醇酸；(R)-(+)-3-羟基-3-苯基丙酸
• 英文名称: (R)-3-phenyl-3-hydroxypropionic acid
• 英文别名: (R)-3-hydroxy-3-phenylpropanoic acid；(R)-3-hydroxy-3-phenylpropionic acid；3-hydroxy-3-phenylpropanoic acid；(3R)-3-hydroxy-3-phenylpropanoic acid
• CAS: 2768-42-5
• 化学式: C₉H₁₀O₃
• mdl: MFCD00145219
• 分子量: 166.177
• InChiKey: AYOLELPCNDVZKZ-MRVPVSSYSA-N

物化性质

• 熔点：
  116-119 °C
• 沸点：
  254.38°C (rough estimate)
• 密度：
  1.1708 (rough estimate)
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36
• 危险类别码：
  R36/37/38
• 海关编码：
  2918199090
• 储存条件：
  存于0至6°C的阴凉干燥处密封保存。

SDS

Name:	(R)-3-Hydroxy-3-Phenylpropanoic Acid Material Safety Data Sheet
Synonym:	None
CAS:	2768-42-5

Section 1 - Chemical Product MSDS Name:(R)-3-Hydroxy-3-Phenylpropanoic Acid Material Safety Data Sheet
Synonym:None

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
2768-42-5	(R)-3-Hydroxy-3-Phenylpropanoic Acid	ca 100	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this material have not been fully investigated.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep refrigerated. (Store below 4C/39F.)

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 2768-42-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 117.0 - 119.0 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H10O3
Molecular Weight: 166.18

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 2768-42-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(R)-3-Hydroxy-3-Phenylpropanoic Acid - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 2768-42-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 2768-42-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2768-42-5 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (R)-(+)-3-羟基-3-苯丙酸 在 溶剂黄146 作用下， 以41%的产率得到肉桂酸
  参考文献：
  名称：

  甲硅烷氧基酯作为羧酸的无痕活化剂：硼催化的化学选择性不对称醛醇反应**

  摘要：

  我们首次开发了一种手性硼催化的、羧酸选择性不对称羟醛反应，该反应适用于后期阶段的多功能底物。计算研究通过作为活性物质的 Si/B 烯二醇使反应机制和立体选择性合理化。

  DOI：

  10.1002/anie.202109788
• 作为产物：
  描述：

  2-bromo-3-hydroxy-3-phenyl-propanoic acid 在 sodium amalgam 、 乙醇 、 硫酸 作用下， 生成 (R)-(+)-3-羟基-3-苯丙酸
  参考文献：
  名称：

  Berner; Riiber, Chemische Berichte, 1921, vol. 54, p. 1957

  摘要：

  DOI：

文献信息

• Substrate Evaluation of<i>Rhodococcus erythropolis</i>SET1, a Nitrile Hydrolysing Bacterium, Demonstrating Dual Activity Strongly Dependent on Nitrile Sub-Structure
  作者：Tracey M. Coady、Lee V. Coffey、Catherine O'Reilly、Claire M. Lennon

  DOI：10.1002/ejoc.201403201

  日期：2015.2

  Rhodococcus erythropolis SET1, a novel nitrile hydrolysing bacterial isolate, has been undertaken with 34 nitriles, 33 chiral and 1 prochiral. These substrates consist primarily of β-hydroxy nitriles with varying alkyl and aryl groups at the β position and containing in several compounds different substituents α to the nitrile. In the case of β-hydroxy nitriles without substitution at the α position

  红球菌 SET1 是一种新型腈水解细菌分离株，已使用 34 种腈、33 种手性和 1 种前手性进行了评估。这些底物主要由 β-羟基腈组成，在 β 位具有不同的烷基和芳基，并且在几种化合物中含有与腈不同的 α 取代基。在 α 位没有取代的 β-羟基腈的情况下，由于分离物的腈水解酶活性，酸是获得的主要产物，以及生物转化后回收的腈。出乎意料的是，当 β-羟基腈在该位置具有乙烯基时，发现酰胺是主要的水解产物。为了进一步探索这种行为，评估了在 α 位置包含吸电子基团的其他相关底物，在 SET1 存在下的生物转化过程中也观察到了酰胺。因此，这种新的分离物也证明了对似乎是底物依赖性的腈类的 NHase 活性。
• Asymmetric Samarium-Reformatsky Reaction of Chiral α-Bromoacetyl-2-oxazolidinones with Aldehydes
  作者：Shin-ichi Fukuzawa、Hiroshi Matsuzawa、Shin-ichi Yoshimitsu

  DOI：10.1021/jo9914317

  日期：2000.3.1

  samarium(II) iodide mediated asymmetric Reformatsky-type reaction of chiral 3-bromoacetyl-2-oxazolidinones with various aldehydes was studied. A series of chiral 4-substituted 2-oxazolidinones 1-3 and 5,5-disubstituted "SuperQuat" oxazolidinones 4-5 were employed as chiral auxiliaries of the alpha-bromoacetic acid. The reaction of 1 with various aldehydes gave the alpha-unbranched beta-hydroxy carboximides

  研究了碘化sa（II）介导的手性3-溴乙酰基-2-恶唑烷酮与各种醛类的不对称Reformatsky型反应。一系列手性的4-取代的2-恶唑烷酮1-3和5，5-二取代的“ SuperQuat”恶唑烷酮4-5用作α-溴乙酸的手性助剂。1与各种醛的反应以高收率和高非对映异构体过量值（高达> 99％de）得到了α-支链的β-羟基羧酰亚胺。源自5,5-二苯基SuperQuat 5的大多数反应产物具有高度结晶性。一次重结晶可得到非对映体纯产物，而其他非对映体则无法通过光谱法检测到。β-羟基羧酰亚胺的绝对构型通过参考文献值通过相应的已知乙酯的旋光度来确定。在温和条件下，使用氢氧化锂很容易实现从辅助SuperQuats水解掉附加的β-羟基部分。得到的相应羧酸和返回的SuperQuats收率很高，没有任何消旋作用的迹象。反应的第一步是还原α-溴基团以生成烯醇，后者会增加醛的含量。发现来自苯甲醛的加合物（7i）
• NOVEL CARBAMOYLOXY ARYLALKANOYL ARYLPIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHOD FOR TREATING PAIN, ANXIETY AND DEPRESSION BY ADMINISTERING THE COMPOUND
  申请人：Kwak Byong Sung

  公开号：US20110195963A1

  公开（公告）日：2011-08-11

  There is provided a novel carbamoyloxy arylalkanoyl arylpiperazine derivative compound having abundant racemic or enantiomeric characteristics, represented by the Formula 1, and pharmaceutically available salts or hydrates thereof. Also, there are provided a pharmaceutical composition for treating pain, anxiety or depression including an effective amount of the compound, and a method for treating pain, anxiety or depression in mammals by administering an effective amount of the compound to the mammals in need of treatment thereof.

  提供一种新颖的卡巴莫氧基芳基丙酰基芳基哌嗪衍生物化合物，具有丰富的外消旋或对映体特征，其化学式如下所示，并且提供其药用盐或水合物。此外，还提供了一种用于治疗疼痛、焦虑或抑郁的药物组合物，包括一定量的该化合物，并且提供了一种治疗哺乳动物疼痛、焦虑或抑郁的方法，通过向需要治疗的哺乳动物施用一定量的该化合物。
• [EN] HETEROCYCLIC INHIBITORS OF GLUTAMINASE<br/>[FR] INHIBITEURS HÉTÉROCYCLIQUES DE GLUTAMINASE
  申请人：CALITHERA BIOSCIENCES INC

  公开号：WO2013078123A1

  公开（公告）日：2013-05-30

  The invention relates to the heterocyclic compounds of Formula (I) as defined further herein, and pharmaceutical preparations thereof. The invention further relates to methods of treating cancer, immunological or neurological diseases using the heterocyclic compounds of the invention.

  本发明涉及式(I)定义的杂环化合物及其药物制剂。本发明进一步涉及使用本发明的杂环化合物治疗癌症、免疫性或神经疾病的方法。
• (R)- and (S)-2-acetoxy-1,1,2-triphenylethanol - effective synthetic equivalents of a chiral acetate enolate
  作者：Manfred Braun、Ralf Devant

  DOI：10.1016/s0040-4039(01)91110-4

  日期：1984.1

  The enolate 3, easily available by double deprotonation of (R)-2- acetoxy-1,1,2-triphenylethanol (5), adds in a highly stereoselective manner to aldehydes. Hydrolysis of the adducts 6/7 affords the acids 2.

  通过（R）-2-乙酰氧基-1,1,2-三苯乙醇（5）的双重去质子化作用容易获得的烯醇化物3以高度立体选择性的方式添加到醛中。加合物6/7的水解产生酸2。